Main navigation | Main content
Rebecca Gerber joined the Office for Technology Commercialization in 2008 after spending 10 years in various pharmaceutical market analysis/research and scientific affairs roles. While working in the pharmaceutical industry, she primarily focused on conducting market assessments and financial forecasts for early-stage compounds as well as scientific and commercial message development.
Rebecca holds an M.B.A and M.S. degrees from the University of Maryland as well as a B.S. degree in Microbiology from Iowa State University.